FY2024 · ended Dec 31, 2024 · Revenue $100,000 · Filed Apr 15, 2026
Profusa, Inc. (PFSA) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. Free cash flow was -$16.3 million. As of Jun 30, 2026 it held $12.2 million in cash and investments and $100,000 in total debt.
Revenue
$100,000
Net income
$-35.82M
-288.1% vs prior year
Operating cash flow (TTM)
$-20.33M
-707.9% vs year-ago TTM
Free cash flow
$-16.26M
EPS
$-107.01
+70.0% vs prior year
Dividend per share
None
Shares outstanding
4.41M
-17.5% vs prior year
Net cash
$12.10M
as of Jun 30, 2026
Operating margin
-4500.0%
FY 2024
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PFSA (Nasdaq), NVACW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1859807
- Former names
- NorthView Acquisition Corp (until Jul 15, 2025)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | — | $100,000 | — | — |
| Operating income | -$27.7M | -$4.5M | -$1.5M | -$1.3M |
| Net income | -$35.8M | -$9.2M | $1.2M | $7.2M |
| Diluted EPS | -$107.01 | -$357.14 | $0.12 | $0.30 |
| Operating cash flow | -$16.2M | -$2.1M | -$2.1M | -$581,189 |
| Free cash flow | -$16.3M | — | — | — |
| Total assets | $3.8M | $3.1M | $10.9M | $194.7M |
| Total liabilities | $30.4M | $57.1M | $5.1M | $1.8M |
| Stockholders' equity | -$26.7M | -$119.2M | -$110.0M | -$619,476 |
| Cash and investments | $1.8M | $191,000 | $4,519 | $193,486 |
| Total debt | — | — | $200,000 | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 15, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Auditor change
|
Oct 9, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 5, 2026 | Oct 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 21, 2026 | Sep 18, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 16, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Other events
|
Sep 15, 2026 | Sep 9, 2026 |
All 323 Profusa, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.